Xtrackers MSCI World Health Care UCITS ETF (LON:XDWH)
London
· Delayed Price · Currency is GBP · Price in USD | Assets | 2.56B |
| Expense Ratio | 0.25% |
| PE Ratio | 22.27 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | -0.81% |
| Volume | 4,919 |
| Open | 51.47 |
| Previous Close | 51.09 |
| Day's Range | 50.90 - 51.47 |
| 52-Week Low | 47.28 |
| 52-Week High | 59.79 |
| Beta | 1.01 |
| Holdings | 163 |
| Inception Date | Nov 22, 2010 |
About XDWH
Xtrackers MSCI World Health Care UCITS ETF is an exchange-traded fund launched by Concept Fund Solutions Public Limited Company. It is co-managed by Deutsche International Corporate Services (Ireland) Limited, Deutsche Asset Management (UK) Limited, and Deutsche Asset Management Investment GmbH. The fund invests in the public equity markets of developed countries across the globe. It seeks to invest in the stocks of companies operating in the healthcare sector. The fund invests in the stocks of large-cap and mid-cap companies. It seeks to replicate the performance of the MSCI World Health Care Total Return Net Index, by investing in the stocks of companies as per their weightings in the index. The fund was formerly known as Concept Fund Solutions plc - db x-trackers MSCI World Health Care Index UCITS ETF (DR). Xtrackers MSCI World Health Care UCITS ETF was formed on November 22, 2010 and is domiciled in Ireland.
Performance
XDWH had a total return of -0.81% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.44%.
Top 10 Holdings
43.16% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 8.80% |
| UnitedHealth Group Incorporated | UNH | 6.37% |
| Johnson & Johnson | JNJ | 5.27% |
| AbbVie Inc. | ABBV | 4.89% |
| Roche Holding AG | ROG | 3.05% |
| Abbott Laboratories | ABT | 3.04% |
| Merck & Co., Inc. | MRK | 3.00% |
| AstraZeneca PLC | AZN | 2.97% |
| Novo Nordisk A/S | NOVO.B | 2.89% |
| Novartis AG | NOVN | 2.88% |